Symbols / RGC Stock $27.32 +3.68% Regencell Bioscience Holdings Limited
RGC (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Ratings
Current target
$27.32
Low
—
High
—
Mean
—
News
RSS: Latest RGC news- RGC Investors Have Opportunity to Lead Regencell Bioscience Holdings Limited Securities Fraud Lawsuit - ChartMill Mon, 11 May 2026 19
- Regencell Bioscience Holdings (RGC) Stock Analysis: Navigating a $14.48 Billion Market Cap Amidst Undefined Financial Metrics - DirectorsTalk Interviews Mon, 11 May 2026 09
- RGC Shareholder Alert: Regencell Bioscience Holdings - GlobeNewswire Mon, 11 May 2026 20
- RGC Deadline Alert: The Gross Law Firm Reminds Regencell Bioscience Holdings Limited (RGC) Investors of Securities Class Action Deadline on June 23, 2026 - Barchart.com ue, 12 May 2026 13
- [6-K] Regencell Bioscience Holdings Ltd Current Report (Foreign Issuer) | RGC SEC Filing - Form 6-K - Stock Titan Fri, 08 May 2026 20
- A Look At Regencell Bioscience Holdings (RGC) Valuation After DOJ Probe And Class Action Lawsuits - simplywall.st Sat, 09 May 2026 23
- A Look At Regencell Bioscience Holdings (RGC) Valuation After Department Of Justice Investigation News - Yahoo Finance Fri, 06 Mar 2026 08
- Number of shareholders of Regencell Bioscience Holdings Limited – NASDAQ:RGC - TradingView Mon, 11 May 2026 04
- RGC Deadline Alert: The Gross Law Firm Reminds Regencell Bioscie - GuruFocus ue, 12 May 2026 18
- RGC Resources Schedules Second-Quarter 2026 Earnings Call - The Globe and Mail Sat, 09 May 2026 13
- Levi & Korsinsky Reminds Regencell Bioscience Holdings Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of June 23, 2026 - RGC - PR Newswire Wed, 06 May 2026 13
- Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limitedand Certain Officers – RGC - ChartMill ue, 12 May 2026 20
- ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Regencell - GlobeNewswire Sat, 09 May 2026 13
- Deadline Alert: Regencell Bioscience Holdings Limited (RGC) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit - ChartMill Fri, 08 May 2026 18
- RGC Investors Have Opportunity to Lead Regencell Bioscience - GlobeNewswire Fri, 08 May 2026 14
Insider Transactions
No recent insider transactions.
Financials
Statement View
| Line Item | Trend | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Expense |
|
4.74
-24.50%
|
6.27
-17.64%
|
7.62
+451.47%
|
1.38
|
| Research And Development |
|
1.07
-32.59%
|
1.58
-37.04%
|
2.51
+473.13%
|
0.44
|
| Selling General And Administration |
|
3.67
-21.77%
|
4.69
-8.10%
|
5.11
+441.40%
|
0.94
|
| Selling And Marketing Expense |
|
0.13
-52.25%
|
0.26
+939.22%
|
0.03
+1503.74%
|
0.00
|
| General And Administrative Expense |
|
3.55
-19.96%
|
4.43
-12.81%
|
5.08
+439.62%
|
0.94
|
| Salaries And Wages |
|
—
|
0.90
-40.00%
|
1.50
|
0.00
|
| Other Gand A |
|
3.55
-19.96%
|
4.43
-12.81%
|
5.08
+439.62%
|
0.94
|
| Total Expenses |
|
4.74
-24.50%
|
6.27
-17.64%
|
7.62
+451.47%
|
1.38
|
| Operating Income |
|
-4.74
+24.50%
|
-6.27
+17.64%
|
-7.62
-451.47%
|
-1.38
|
| Total Operating Income As Reported |
|
-4.74
+24.50%
|
-6.27
+17.64%
|
-7.62
-451.47%
|
-1.38
|
| EBITDA |
|
-3.99
+27.49%
|
-5.50
+21.52%
|
-7.01
-417.63%
|
-1.35
|
| Normalized EBITDA |
|
-3.99
+27.49%
|
-5.50
+21.52%
|
-7.01
-417.63%
|
-1.35
|
| Reconciled Depreciation |
|
0.75
-3.13%
|
0.77
+27.35%
|
0.60
+2184.54%
|
0.03
|
| EBIT |
|
-4.74
+24.50%
|
-6.27
+17.64%
|
-7.62
-451.47%
|
-1.38
|
| Net Income |
|
-4.30
+26.73%
|
-5.87
+21.15%
|
-7.45
-452.88%
|
-1.35
|
| Pretax Income |
|
-4.36
+28.03%
|
-6.06
+20.18%
|
-7.59
-463.92%
|
-1.35
|
| Other Income Expense |
|
0.37
+76.73%
|
0.21
+810.37%
|
0.02
-32.94%
|
0.03
|
| Other Non Operating Income Expenses |
|
0.37
+76.73%
|
0.21
+810.37%
|
0.02
-32.94%
|
0.03
|
| Tax Provision |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-4.36
+28.03%
|
-6.06
+20.18%
|
-7.59
-463.92%
|
-1.35
|
| Net Income From Continuing Operation Net Minority Interest |
|
-4.30
+26.73%
|
-5.87
+21.15%
|
-7.45
-452.88%
|
-1.35
|
| Net Income From Continuing And Discontinued Operation |
|
-4.30
+26.73%
|
-5.87
+21.15%
|
-7.45
-452.88%
|
-1.35
|
| Net Income Continuous Operations |
|
-4.36
+28.03%
|
-6.06
+20.18%
|
-7.59
-463.92%
|
-1.35
|
| Minority Interests |
|
0.06
-67.90%
|
0.19
+28.66%
|
0.15
|
0.00
|
| Normalized Income |
|
-4.30
+26.73%
|
-5.87
+21.15%
|
-7.45
-452.88%
|
-1.35
|
| Net Income Common Stockholders |
|
-4.30
+26.73%
|
-5.87
+21.15%
|
-7.45
-452.88%
|
-1.35
|
| Diluted EPS |
|
-0.01
+26.89%
|
-0.01
+22.03%
|
-0.02
-444.52%
|
-0.00
|
| Basic EPS |
|
-0.01
+26.89%
|
-0.01
+22.03%
|
-0.02
-444.52%
|
-0.00
|
| Basic Average Shares |
|
494.49
+0.00%
|
494.49
+1.62%
|
486.62
+1.29%
|
480.40
|
| Diluted Average Shares |
|
494.49
+0.00%
|
494.49
+1.62%
|
486.62
+1.29%
|
480.40
|
| Diluted NI Availto Com Stockholders |
|
-4.30
+26.73%
|
-5.87
+21.15%
|
-7.45
-452.88%
|
-1.35
|
| Line Item | Trend | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Total Assets |
|
8.44
-33.15%
|
12.62
-29.95%
|
18.02
+5197.59%
|
0.34
|
| Current Assets |
|
8.11
-30.18%
|
11.62
-29.33%
|
16.44
+24499.61%
|
0.07
|
| Cash Cash Equivalents And Short Term Investments |
|
7.96
-31.16%
|
11.56
-29.56%
|
16.42
+27532.00%
|
0.06
|
| Cash And Cash Equivalents |
|
2.96
+89.24%
|
1.56
-75.61%
|
6.42
+10700.66%
|
0.06
|
| Cash Financial |
|
2.96
+89.24%
|
1.56
-75.61%
|
6.42
+10700.66%
|
0.06
|
| Other Short Term Investments |
|
5.00
-50.00%
|
10.00
+0.00%
|
10.00
|
0.00
|
| Receivables |
|
0.15
+170.17%
|
0.06
+104.90%
|
0.03
+271.14%
|
0.01
|
| Other Receivables |
|
0.15
+170.17%
|
0.06
+104.90%
|
0.03
+271.14%
|
0.01
|
| Prepaid Assets |
|
—
|
—
|
0.03
+271.14%
|
0.01
|
| Total Non Current Assets |
|
0.32
-67.59%
|
1.00
-36.45%
|
1.57
+476.07%
|
0.27
|
| Net PPE |
|
0.23
-74.60%
|
0.89
-38.91%
|
1.46
+1683.45%
|
0.08
|
| Gross PPE |
|
1.01
-26.12%
|
1.37
-16.89%
|
1.65
+1296.96%
|
0.12
|
| Accumulated Depreciation |
|
-0.78
-64.68%
|
-0.48
-155.84%
|
-0.19
-417.40%
|
-0.04
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
0.30
+2.21%
|
0.30
-0.54%
|
0.30
|
0.00
|
| Other Properties |
|
0.08
-81.21%
|
0.45
-39.65%
|
0.75
|
—
|
| Leases |
|
0.62
+0.38%
|
0.62
+3.31%
|
0.60
+410.47%
|
0.12
|
| Non Current Deferred Assets |
|
—
|
—
|
0.00
-100.00%
|
0.17
|
| Non Current Prepaid Assets |
|
0.10
-9.97%
|
0.11
-5.08%
|
0.11
+498.25%
|
0.02
|
| Total Liabilities Net Minority Interest |
|
0.22
-65.28%
|
0.63
-32.59%
|
0.94
-78.38%
|
4.34
|
| Current Liabilities |
|
0.19
-68.10%
|
0.61
+5.05%
|
0.58
-86.68%
|
4.34
|
| Payables And Accrued Expenses |
|
0.13
-20.68%
|
0.17
+1.12%
|
0.17
-74.57%
|
0.66
|
| Payables |
|
0.01
-20.12%
|
0.01
-32.46%
|
0.02
-81.10%
|
0.08
|
| Current Accrued Expenses |
|
0.13
-20.72%
|
0.16
+4.60%
|
0.15
-73.62%
|
0.57
|
| Current Debt And Capital Lease Obligation |
|
0.06
-86.35%
|
0.44
+6.64%
|
0.41
-88.84%
|
3.68
|
| Current Debt |
|
—
|
—
|
—
|
3.68
|
| Other Current Borrowings |
|
—
|
—
|
—
|
3.68
|
| Current Capital Lease Obligation |
|
0.06
-86.35%
|
0.44
+6.64%
|
0.41
|
0.00
|
| Total Non Current Liabilities Net Minority Interest |
|
0.03
+2.08%
|
0.03
-92.95%
|
0.36
|
0.00
|
| Long Term Debt And Capital Lease Obligation |
|
0.03
+2.08%
|
0.03
-92.95%
|
0.36
|
0.00
|
| Long Term Capital Lease Obligation |
|
0.03
+2.08%
|
0.03
-92.95%
|
0.36
|
0.00
|
| Stockholders Equity |
|
8.22
-31.68%
|
12.03
-29.50%
|
17.07
+526.89%
|
-4.00
|
| Common Stock Equity |
|
8.22
-31.68%
|
12.03
-29.50%
|
17.07
+526.89%
|
-4.00
|
| Capital Stock |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
+30.00%
|
0.00
|
| Common Stock |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
+30.00%
|
0.00
|
| Share Issued |
|
494.49
+0.00%
|
494.49
+0.00%
|
494.49
+2.93%
|
480.40
|
| Ordinary Shares Number |
|
494.49
+0.00%
|
494.49
+0.00%
|
494.49
+2.93%
|
480.40
|
| Additional Paid In Capital |
|
29.88
+1.53%
|
29.43
+3.24%
|
28.51
+11136346.88%
|
0.00
|
| Retained Earnings |
|
-21.62
-24.84%
|
-17.32
-51.30%
|
-11.44
-186.24%
|
-4.00
|
| Gains Losses Not Affecting Retained Earnings |
|
-0.05
+47.19%
|
-0.09
|
0.00
|
—
|
| Minority Interest |
|
0.00
+100.00%
|
-0.04
-365.78%
|
0.02
|
0.00
|
| Other Equity Adjustments |
|
-0.05
+47.19%
|
-0.09
|
—
|
—
|
| Total Equity Gross Minority Interest |
|
8.22
-31.45%
|
11.99
-29.81%
|
17.08
+527.27%
|
-4.00
|
| Total Capitalization |
|
8.22
-31.68%
|
12.03
-29.50%
|
17.07
+526.89%
|
-4.00
|
| Working Capital |
|
7.92
-28.09%
|
11.01
-30.58%
|
15.87
+471.51%
|
-4.27
|
| Invested Capital |
|
8.22
-31.68%
|
12.03
-29.50%
|
17.07
+5506.15%
|
-0.32
|
| Total Debt |
|
0.09
-81.51%
|
0.46
-39.88%
|
0.77
-79.05%
|
3.68
|
| Net Debt |
|
—
|
—
|
—
|
3.62
|
| Capital Lease Obligations |
|
0.09
-81.51%
|
0.46
-39.88%
|
0.77
|
0.00
|
| Net Tangible Assets |
|
8.22
-31.68%
|
12.03
-29.50%
|
17.07
+526.89%
|
-4.00
|
| Tangible Book Value |
|
8.22
-31.68%
|
12.03
-29.50%
|
17.07
+526.89%
|
-4.00
|
| Dueto Related Parties Current |
|
0.01
-20.12%
|
0.01
-32.46%
|
0.02
-81.10%
|
0.08
|
| Line Item | Trend | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-4.00
+19.37%
|
-4.96
+5.77%
|
-5.27
-586.43%
|
-0.77
|
| Cash Flow From Continuing Operating Activities |
|
-4.00
+19.37%
|
-4.96
+5.77%
|
-5.27
-586.43%
|
-0.77
|
| Net Income From Continuing Operations |
|
-4.36
+28.03%
|
-6.06
+20.18%
|
-7.59
-463.92%
|
-1.35
|
| Depreciation Amortization Depletion |
|
0.75
-3.13%
|
0.77
+27.35%
|
0.60
+2184.54%
|
0.03
|
| Depreciation |
|
0.75
-3.13%
|
0.77
+27.35%
|
0.60
+2184.54%
|
0.03
|
| Depreciation And Amortization |
|
0.75
-3.13%
|
0.77
+27.35%
|
0.60
+2184.54%
|
0.03
|
| Other Non Cash Items |
|
-0.25
-190.40%
|
-0.09
-695.68%
|
-0.01
|
—
|
| Stock Based Compensation |
|
0.45
-51.30%
|
0.92
-66.55%
|
2.76
|
0.00
|
| Operating Gains Losses |
|
—
|
0.00
|
—
|
—
|
| Gain Loss On Sale Of PPE |
|
0.00
-100.00%
|
0.00
|
0.00
|
0.00
|
| Change In Working Capital |
|
-0.59
-15.02%
|
-0.51
+50.30%
|
-1.02
-285.19%
|
0.55
|
| Change In Prepaid Assets |
|
-0.09
-269.01%
|
-0.02
+77.88%
|
-0.10
-1237.23%
|
-0.01
|
| Change In Payables And Accrued Expense |
|
-0.03
-1961.26%
|
0.00
+100.38%
|
-0.49
-187.20%
|
0.56
|
| Change In Accrued Expense |
|
-0.03
-571.00%
|
0.01
+101.65%
|
-0.42
-188.26%
|
0.48
|
| Change In Payable |
|
-0.00
+58.13%
|
-0.01
+92.44%
|
-0.07
-181.10%
|
0.08
|
| Change In Other Current Liabilities |
|
-0.47
+4.63%
|
-0.49
-13.30%
|
-0.43
|
0.00
|
| Investing Cash Flow |
|
5.24
+8789.12%
|
0.06
+100.55%
|
-10.78
|
0.00
|
| Cash Flow From Continuing Investing Activities |
|
5.24
+8789.12%
|
0.06
+100.55%
|
-10.78
|
0.00
|
| Net PPE Purchase And Sale |
|
-0.01
+79.65%
|
-0.03
+96.62%
|
-0.78
|
0.00
|
| Purchase Of PPE |
|
-0.01
+80.37%
|
-0.03
+96.49%
|
-0.78
|
0.00
|
| Sale Of PPE |
|
0.00
-100.00%
|
0.00
|
0.00
|
0.00
|
| Capital Expenditure |
|
-0.01
+80.37%
|
-0.03
+96.49%
|
-0.78
|
—
|
| Net Investment Purchase And Sale |
|
5.25
+6045.20%
|
0.09
+100.85%
|
-10.00
|
0.00
|
| Purchase Of Investment |
|
-5.00
+50.00%
|
-10.00
+0.00%
|
-10.00
|
0.00
|
| Sale Of Investment |
|
10.25
+1.61%
|
10.09
|
0.00
|
0.00
|
| Financing Cash Flow |
|
0.10
-24.19%
|
0.13
-99.40%
|
22.41
+4995.12%
|
0.44
|
| Cash Flow From Continuing Financing Activities |
|
0.10
-24.19%
|
0.13
-99.40%
|
22.41
+4995.12%
|
0.44
|
| Net Issuance Payments Of Debt |
|
0.00
|
0.00
+100.00%
|
-0.43
-170.58%
|
0.61
|
| Issuance Of Debt |
|
—
|
—
|
—
|
0.61
|
| Short Term Debt Issuance |
|
—
|
—
|
—
|
0.61
|
| Net Short Term Debt Issuance |
|
0.00
|
0.00
+100.00%
|
-0.43
-170.58%
|
0.61
|
| Net Common Stock Issuance |
|
0.00
|
0.00
-100.00%
|
22.67
|
0.00
|
| Net Other Financing Charges |
|
0.10
-24.19%
|
0.13
-17.74%
|
0.16
+195.18%
|
-0.17
|
| Changes In Cash |
|
1.34
+128.17%
|
-4.77
-175.01%
|
6.36
+2040.86%
|
-0.33
|
| Effect Of Exchange Rate Changes |
|
0.05
+164.01%
|
-0.08
|
0.00
|
0.00
|
| Beginning Cash Position |
|
1.56
-75.61%
|
6.42
+10700.66%
|
0.06
-84.65%
|
0.39
|
| End Cash Position |
|
2.96
+89.24%
|
1.56
-75.61%
|
6.42
+10700.66%
|
0.06
|
| Free Cash Flow |
|
-4.01
+19.70%
|
-4.99
+17.49%
|
-6.05
-688.20%
|
-0.77
|
| Interest Paid Supplemental Data |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Income Tax Paid Supplemental Data |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Common Stock Issuance |
|
0.00
|
0.00
-100.00%
|
22.67
|
0.00
|
| Issuance Of Capital Stock |
|
0.00
|
0.00
-100.00%
|
22.67
|
0.00
|
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|